Focal Segmental Glomerulosclerosis
Open accessThe DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease worldwide. The presumed etiology of primary FSGS is a plasma factor with responsiveness to immunosuppressive therapy and a risk of recurrence after kidney transplant–important disease characteristics. In contrast, adaptive FSGS is associated with excessive nephron workload due to increased body size, reduced nephron capacity, or single glomerular hyperfiltration associated with certain diseases. Additional etiologies are now recognized as drivers of FSGS: high-penetrance genetic FSGS due to mutations in one of nearly 40 genes, virus-associated FSGS, and medication-associated FSGS. Emerging data support the identification of a sixth category: APOL1 risk allele–associated FSGS in individuals with sub-Saharan ancestry. The classification of a particular patient with FSGS relies on integration of findings from clinical history, laboratory testing, kidney biopsy, and in some patients, genetic testing. The kidney biopsy can be helpful, with clues provided by features on light microscopy ( e.g ., glomerular size, histologic variant of FSGS, microcystic tubular changes, and tubular hypertrophy), immunofluorescence ( e.g ., to rule out other primary glomerulopathies), and electron microscopy ( e.g. , extent of podocyte foot process effacement, podocyte microvillous transformation, and tubuloreticular inclusions). A complete assessment of renal histology is important for establishing the parenchymal setting of segmental glomerulosclerosis, distinguishing FSGS associated with one of many other glomerular diseases from the clinical-pathologic syndrome of FSGS. Genetic testing is beneficial in particular clinical settings. Identifying the etiology of FSGS guides selection of therapy and provides prognostic insight. Much progress has been made in our understanding of FSGS, but important outstanding issues remain, including the identity of the plasma factor believed to be responsible for primary FSGS, the value of routine implementation of genetic testing, and the identification of more effective and less toxic therapeutic interventions for FSGS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Focal segmental glomerulosclerosis (FSGS) is a fibrotic kidney disease characterized by glomerular lesions, particularly in podocytes — the formation of adhesions in the glomerular capillary tuft leads to capillary occlusion and nephron degeneration162.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [162]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028 · cited 1×
“More recently, efforts to identify genetic drivers of FSGS in at-risk populations have gained momentum, with the most recent addition including the APOL1 genetic variant as a major association with FSGS in individuals of sub-Saharan African descent with FSGS (23).”
BackgroundSelf-citationMann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
KDIGO Clinical Practice Guideline for Glomerulonephritis
Eckardt, K., & Kasiske, B. L. (2012) · Cited by 893
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationCirculating urokinase receptor as a cause of focal segmental glomerulosclerosis
Wei, C., El Hindi, S., Li, J., Fornoni, A., Goes, N., Sageshima, J., Maiguel, D., Karumanchi, S. A., Yap, H.-K., Saleem, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2411 · Cited by 841
Cited by
Items 601–642 of 642
Yıldırım, M. E. (2026) · Bozok Tıp Dergisi · doi:10.16919/bozoktip.1758051
Ahmed, L. I., Mohammed, D. A., & Sharif, D. A. (2026) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2026.101330
Tanaka, A., Furuhashi, K., Sakamoto, S., Horinouchi, A., Fujieda, K., Matsumoto, J., Hattori, K., Onogi, C., Kawazoe, T., Kato, A., et al. (2026) · Stem Cells and Development · doi:10.1177/15473287261460636
Narasimhareddy, B., Reddy, G. S., Surisetty, Y., & Srinivasadesikan, V. (2026) · Synthetic Communications · doi:10.1080/00397911.2026.2691825
Pathogenesis of Focal Segmental Glomerulosclerosis: From Podocyte Injury to Precision Therapy
Wu, Q., & Chen, Z. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101460
Sewerin, S., Aurnhammer, C., Hamed, M., Revêchon, G., Schönauer, R. A.-R., Findeisen, C., Miehle, K., Tesařová, Š., Georgomanolis, T., Bergmann, C., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.192062
Santos, R. O., Lima, C. F., & Almeida, L. M. (2026) · International Journal of Chemical and Biological Sciences · doi:10.33545/26646765.2026.v8.i6a.235
Gembillo, G., Casuscelli, C., Spada, A. L., Pietro, Y. D., Cipressa, G., Santoro, D., & Re, C. L. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2706076
Nyabera, A., & Appel, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34069-7.00019-7
Investigating the Role of Inflammatory Cytokine Genes in Glomerular Disease
Raghul Priyadharson, S., Geminiganesan, S., Ekambaram, S., Balraj, T. H., Mathews, S. G., & Priya, C. D. M. (2026) · Current Pediatrics Reports · doi:10.1007/s40124-026-00381-1
Xu, Y., Gao, J., Wen, Y., Li, R., Jiang, M., Pei, Y., Chen, L., Rong, L., & Jiang, X. (2026) · Research Square · doi:10.21203/rs.3.rs-10439674/v1
Yang, F., Wang, X., Li, Y., Su, K., Ding, R., Wu, L., Ma, G., Yang, J., & Li, Z. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1913168
Collapsing Glomerulopathy in a Patient With Malaria and Multiple Myeloma: A Case Report
Harenberg, M., Amann, K., & Zickler, D. (2026) · Case Reports in Medicine · doi:10.1155/carm/9149610
Mattias, F., Tsoy, O. V., Iervolino, A., Simm, S., Hammer, E., Greß, A., Siegerist, F., Schindler, M., Lange, T., Ameling, S., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00495-5
Focal Segmental Glomerulosclerosis - From Etiology to Treatment
Brečko, T., Večerić-Haler, Ž., & Kojc, N. (2025) · DiRROS repository (University of Maribor)
Luo, J., Yan, Y., Tian, J., Su, L., & 王国保 (2026) · Research Square · doi:10.21203/rs.3.rs-10352353/v1
Xu, Y., Chen, S., Zhang, Y., Li, Y., & Li, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1852918
Monoclonal antibodies associated IgA nephropathy or other nephropathies
Miedziaszczyk, M., Kosiorowski, G., Kubasik, J., Grabowski, T., Szałek, E., Szeto, C. C., & Idasiak‐Piechocka, I. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1891000
Clinical heterogeneity in biopsy-proven adult focal segmental glomerulosclerosis
Ammara, K., Khan, A., Lonikar, M., & Gani, T. A. A. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20263552
Eum, S. H., Koh, E. S., Chung, B. H., Ban, T. H., Min, J. W., Kim, H. W., Hong, Y. A., Choi, B. S., Shin, S. J., Kim, Y., et al. (2026) · Kidney & Blood Pressure Research · doi:10.1159/kbr/adjag009
Urinary Endoplasmic Reticulum (ER) Chaperones: Biomarkers of Glomerular ER Stress
Cybulsky, A. V., Papillon, J., Tousson-Abouelazm, N., Alam, A., & Baroz, F. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.20263xbr0e5j
Rangasamy, S. (2025) · Journal of chemical health risks
Air Pollution, Pregnancy and DNA mutations
Cocchi, E. (n.d.) · Institutional Research Information System University of Turin (University of Turin)
An Overview on Nephrotic Syndrome
El-Bastawesi, H. M. B. (2024) · The International Journal of Multiphysics
Langner, E., Parra, K., Jiang, S., Jain, S. R., Mahjoub, M. R., Genin, G. M., Miner, J. H., & Suleiman, H. Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.07.757076
Sarker, M. S., Haq, M. A., Barman, M., Podder, A., Sarker, A., Sultana, S., & Matin, M. R. A. (2026) · Naogaon Medical College Journal · doi:10.70818/nmcj.v03i01.076
Ma, J., Ma, T., Zhang, Y., & Wei, H. (2026) · iScience · doi:10.1016/j.isci.2026.118015
BindingDB (2024) · UC San Diego · doi:10.7270/q2m90f31
NF2 Inhibits CMPK2-Driven NLRP3 Inflammasome Activation to Alleviate Podocyte Injury in FSGS
Yang, L., Tan, Q., Yin, H., Qiu, L., Zhou, X., Jiang, H., Yang, Q., Xiao, H., Jiang, W., Yang, X., et al. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s615100
HUANG, C.-W., CHEN, H.-H., & CHEN, J.-S. (2026) · In Vivo · doi:10.21873/invivo.14492
Case 26: A 75-Year-Old Man Presenting With Leg Edema and Proteinuria
Kim, Y., Hong, S., Youn, S., Kwon, J., & Kim, H. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e309
Rahul, Ramachandran, V., Kumar, K. H., & Kishore Karthik, S. (2026) · Adolescencia e Saude · doi:10.67440/ahj.vi.2864
Zagorec, N., Horvatić, I., Kasumović, D., Osmani, B., Sović, S., Horaček, M., Šenjug, P., Gales̃ić, K., & Ljubanović, D. G. (2026) · Nephrology · doi:10.1111/nep.70306
Trachtman, H., & Coppock, G. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101611
Lin, X., HUANG, G., Sun, Q., & Zhang, X. (2026) · PLoS ONE · doi:10.1371/journal.pone.0361466
Wang, X., Xiang, J., Huang, G., Kang, L., Yang, G., Wu, H., Jiang, K., Liang, Z., & Yang, S. (2021) · doi:10.3389/fphar.2021.779652.s001
Marinaki, S., Kompotiatis, P., Michelakis, I., Stangou, M., Papagianni, A., Koukoulaki, M., Zerbala, S., Xydakis, D., Kaperonis, N., Dounousi, E., et al. (2024) · doi:10.1371/journal.pone.0315124.r003
Supporting information 5 of The Wnt Signaling Pathway in Diabetic Nephropathy
Wang, H., Zhang, R., Wu, X., Chen, Y., Ji, W., Wang, J., Zhang, Y., Xia, Y., Tang, Y., & Yuan, J. (2022) · doi:10.3389/fcell.2021.701547.s005
Chung, C.-F., Papillon, J., Navarro-Betancourt, J. R., Guillemette, J., Bhope, A., Emad, A., & Cybulsky, A. V. (2023) · doi:10.3389/fmed.2023.1122328.s002
Possemiers, H., Pollenus, E., Prenen, F., Knoops, S., Koshy, P., & den Steen, P. E. V. (2022) · doi:10.3389/fcimb.2022.915792.s002
Metadata
- Authors
- Rosenberg, A. Z., & Kopp, J. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Rosenberg, Avi Z.
- Kopp, Jeffrey B.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-02-27
- Volume
- 12
- Issue
- 3
- Pages
- 502-517
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5338705
- OpenAlex
- W2593771998
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 43 · 2025: 71 · 2024: 86 · 2023: 79 · 2022: 79 · 2021: 62 · 2020: 65 · 2019: 46 · 2018: 22 · 2017: 9
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- focal segmental glomerulosclerosis, APOL1 risk alleles, renal biopsy, podocyte ultrastructure, genetic testing
- MeSH terms
- Apolipoprotein L1, Angiotensin-Converting Enzyme Inhibitors, Drug Therapy, Combination, Glomerulosclerosis, Focal Segmental, Glucocorticoids, Humans, Immunosuppressive Agents, HIV Infections, Angiotensin Receptor Antagonists, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.